AutoSTEA Device for Indigestion
What You Need to Know Before You Apply
What is the purpose of this trial?
The goal of this study is to assess the acceptance and usability as well as safety of the AutoSTEA device is in treating epigastric pain syndrome in adults. It will also explore preliminary clinical and mechanistic signals. The main questions it aims to answer are:
* Does the AutoSTEA device ease epigastric pain symptoms?
* Is the AutoSTEA device safe and feasible for patients to use at their home?
Participants will:
* Use the device for 30-60 minutes at home each day for 4 weeks
* Have a phone check-in four times through the trial (once a week).
* Answer the daily and weekly questionnaires which consist of questions regarding symptoms, device usability, and adverse events experienced.
Are You a Good Fit for This Trial?
This trial is for adults who have indigestion with upper stomach pain (epigastric pain syndrome). Participants must be able to use a device at home daily and answer questionnaires. Specific inclusion or exclusion details are not provided.Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- AutoSTEA device
Trial Overview
The study tests the AutoSTEA device, which is used at home for 30-60 minutes daily over 4 weeks, compared to a sham (inactive) treatment. The main focus is on safety, ease of use, and whether it helps relieve symptoms.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
This arm will receive the experimental treatment for 4 weeks.
This arm will first receive the sham treatment for 4 weeks.
Find a Clinic Near You
Who Is Running the Clinical Trial?
MetroHealth Medical Center
Lead Sponsor
National Institutes of Health (NIH)
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.